Loading
A live screen of the small-cap universe ordered by coverage-gap score — a composite of analyst count, last-coverage-change recency, and fundamental signal strength. Filter by cap, exchange, sector, and tier. Every row links to a source-backed profile.
State is in the URL. Share a filtered screen by copying the link.
| Ticker | Name · sector | Cap | ADV | Analysts | Tier | Gap , sorted descending | Why surfaced |
|---|---|---|---|---|---|---|---|
| MTXYVNASDAQ | Orval Foods Consumer | $98M | $0.3M/d | 0 | no coverage | 89 | Capacity-utilization step-up not present in the prior analyst note's model. |
| TJKMNASDAQ | Ulmar Bio Healthcare | $461M | $2.0M/d | 0 | no coverage | 83 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| SGCPZNASDAQ | Ulmar Brands Consumer | $371M | $2.3M/d | 0 | no coverage | 80 | Capacity-utilization step-up not present in the prior analyst note's model. |
| DPUMCOTC | Penna Therapeutics Healthcare | $466M | $1.8M/d | 0 | no coverage | 79 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| ZVJWVAMEX | Zephir Pet Consumer | $96M | $0.4M/d | 1 | low coverage | 76 | Regulatory change opens a reimbursement vector the last sell-side note didn't price. |
| UCZNNASDAQ | Borvel Therapeutics Healthcare | $351M | $0.9M/d | 0 | no coverage | 75 | Bookings disclosure expanded; consensus model still references the prior format. |
| GNRBAMEX | Ember Health Healthcare | $30M | $0.0M/d | 2 | low coverage | 75 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| WPGHNYSE | Hexor Sciences Healthcare | $49M | $0.2M/d | 1 | low coverage | 74 | No-coverage screen flag; recent insider buying not yet modeled. |
| AFVVOTC | Drayve Therapeutics Healthcare | $72M | $0.5M/d | 1 | low coverage | 72 | Capacity-utilization step-up not present in the prior analyst note's model. |
| KULSAMEX | Zephir Goods Consumer | $46M | $0.1M/d | 1 | low coverage | 60 | Bookings disclosure expanded; consensus model still references the prior format. |
| JXCZOTC | Westra Foods Consumer | $620M | $0.8M/d | 6 | covered | 41 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| DURPOTC | Marn Pet Consumer | $76M | $0.4M/d | 5 | covered | 34 | Bookings disclosure expanded; consensus model still references the prior format. |